Möchten Sie immer auf dem neuesten Stand bleiben?

Dublin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The "Sustainable Business Models in an Increasingly Risky and Uncertain Future Training Course (Jan 23, 2026)" training has been added to ...

Toronto, ON, Nov. 03, 2025 (GLOBE NEWSWIRE) --  BetWhale is setting new benchmarks in the rapidly advancing world of online gaming for 2025, expertly blending the power of cryptocurrency...

–Publication highlights Deramiocel’s anti-fibrotic activity and describes a validated potency assay supporting quality control and product consistency in late-stage development–  SAN DIEGO, Nov. 03,...

– Data to be featured in two oral presentations on December 8, 2025 – – Broad development program assesses ziftomenib across diverse AML segments and treatment paradigms to inform appropriate use – ...

– 12 revumenib and 11 axatilimab abstracts accepted, including 6 oral presentations, underscoring Syndax’s leadership in menin inhibition and CSF-1R inhibition – – Revumenib abstracts showcase...

Unprecedented Phase 1 CML efficacy data with 64% MMR achievement by 24 weeks in a refractory patient population Encouraging safety and tolerability profile at all doses evaluated Company to host...

Agios today announced that new data on mitapivat, an oral pyruvate kinase activator, will be featured in oral and poster presentations during ASH

Austin, Nov. 03, 2025 (GLOBE NEWSWIRE) -- RNAi Technology Market Size & Growth Analysis According to SNS Insider, the global RNAi Technology Market was valued at USD 3.02 billion in 2024 and is...

Ottawa, Nov. 03, 2025 (GLOBE NEWSWIRE) -- The global organoids market size was valued at USD 69.90 million in 2024 and is predicted to hit around USD 381.7 million by 2034, rising at a 18.5% CAGR, a...

MONTREAL and CHARLOTTE, N.C., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of...